11 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... ivermectin… #COVID19 ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... infection Episode #Pharmacology ... #Management #CDiff
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
C.diff - Clostridioides ... Diagnosis and Management ... Pathophysiology: Spore ... (IDSA 2021): ... ciab549 #CDI #Cdiff
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... in setting of short ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... 19 - Zika virus ... • Weakness: Starts ... Syndrome #diagnosis #management
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
× 10 days #CDiff ... options #treatment #management ... #pharmacology # ... idsa #table
COVID19 - Community Mitigation Strategy
In the 1st (steepest) curve, virus reproduces quickly in a short period
COVID19 - Community ... steepest) curve, virus ... reproduces quickly in a short ... Vaccinologist #COVID19 ... SocialDistancing #Management
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Herpes Simplex Virus ... HerpesSimplex #HSV #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology